NCT01458509

Brief Summary

It can be difficult to obtain the perspective of patients who have had bowel surgery. This study is being done because the investigators are trying to find out whether patient-reported outcomes, (results reported to investigators by the patient), on a regular basis, will help the investigators provide better patient care and symptom management. Therefore, the purpose of this study is to determine if it is possible and if it is useful to their medical care for patients who have had bowel surgery to complete surveys about their symptoms on a regular basis. In this study the surveys are completed from home, by web or by telephone, every month for 6 months. The results of this study will guide the design of large research studies on cancer-related bowel function. The purpose of this study is to develop a bowel function questionnaire for patients with colorectal cancer. The questionnaire will be used in future clinical trials to assess bowel function.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
325

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 11, 2011

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

October 18, 2011

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 25, 2011

Completed
9.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 8, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 8, 2021

Completed
Last Updated

September 10, 2021

Status Verified

September 1, 2021

Enrollment Period

9.9 years

First QC Date

October 18, 2011

Last Update Submit

September 9, 2021

Conditions

Keywords

Quality of Lifepatient outcomesquestionaires11-101

Outcome Measures

Primary Outcomes (2)

  • clinically useful to collect patient-reported data

    using electronic methods (interactive voice response system (IVRS) or web interface)

    6 months

  • feasibility of electronic PRO assessment

    we define feasibility as being the completion of 4/6 surveys. A complete survey is defined as having responses to 17/24 items (70%) on the survey. The administration mode will be deemed feasible if \>=70% of patients complete 4/6 surveys.

    2 years

Secondary Outcomes (2)

  • psychometric equivalence

    2 years

  • problems people experience

    2 years

Study Arms (4)

IVRS ( interactive voice response system) EASP

Telephone Group with Nurse Intervention

Behavioral: surveys

Web EASP

Web Group with Nurse Intervention

Behavioral: surveys

IVRS ( interactive voice response system) No EASP

Telephone Group without nurse intervention

Behavioral: surveys

Web No EASP

Web Group without nurse intervention

Behavioral: Surveys

Interventions

SurveysBEHAVIORAL

IVRS: An interactive voice response system (IVRS) is an automated telephone platform. The IVRS system will allow the participant to complete the survey when they receive the call and/or to call the system within the survey window to complete the survey. In each group, administration of a survey including the BFI, PRO-CTCAE sexual function items, and QOL LASA and in each group, the survey will be conducted once a month over a six-month period. The intervention will be an email alert to study personnel (EASP). Patients randomized to EASP will receive a phone call if their bowel function by the clinical office nurse if the study personnel determine that the patient's BFI, as reported on the monthly survey, is less than 53 (lowest quartile scores). Interventions that may occur include dietary and/or medication advice at the discretion of the office staff.

IVRS ( interactive voice response system) EASP

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients will be screened in colorectal surgery clinics on the 3rd floor of the MSKCC 53rd Street outpatient clinic buildings or at the Main Hospital at 1275 York Avenue or while they are an inpatients. Patients will be approached within 1-5 weeks post operatively to ensure that they can complete the first survey within the 4-6 week window.

You may qualify if:

  • Aim 1:
  • Stage I-III rectal cancer
  • Post sphincter preserving surgery with restoration of bowel continuity within last 4-6 weeks at MSKCC.
  • Access to web and email from home
  • Web avidity (≥2 uses of email/week)
  • Able to read and write in English
  • Age ≥ 18
  • Aim 2:
  • Stage I-III colon and rectal cancer
  • Post surgical resection of primary tumor at MSKCC
  • Access to web and email from home
  • Web avidity (≥2 uses of email/week)
  • Able to read and write in English
  • Age ≥ 18

You may not qualify if:

  • Aim 1:
  • Metastatic disease - Auditory, visual or motor impairment that would preclude ability to use telephone and/or computer.
  • Stoma
  • Participated in Aim 2
  • Definitive SPS = Transanal Excision (TAE) or Transanal Endoscopic Microsurgery (TEM)
  • Aim 2:
  • Metastatic disease - Auditory, visual or motor impairment that would preclude ability to use telephone and/or computer.
  • Stoma
  • Participated in Aim 1

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Memorial Sloan-Kettering Cancer Center

New York, New York, 10065, United States

Location

Related Links

MeSH Terms

Conditions

Colonic NeoplasmsRectal Neoplasms

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Julio Garcia-Aguilar, MD, PhD

    Memorial Sloan Kettering Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 18, 2011

First Posted

October 25, 2011

Study Start

October 11, 2011

Primary Completion

September 8, 2021

Study Completion

September 8, 2021

Last Updated

September 10, 2021

Record last verified: 2021-09

Locations